Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating JZP150 for Once-Daily Treatment of Adults with Post-Traumatic Stress Disorder
Spoke,
U.S. FDA granted JZP150 Fast Track designation in PTSD, underscoring the unmet needs of patients If approved, JZP150 would…